Melanie Majure, MD
Associate Professor
Medicine
School of Medicine

Education & Training

Show all (4) Hide

• Hematology/Oncology Fellowship UCSF 11/2015
• Internal Medicine Residency Stanford University Hospital and Clinics 10/2012
• MD Stanford University School of Medicine 06/2009
• BS Neuroscience Davidson College 05/2000

Publications (32)

Top publication keywords:
Triple Negative Breast NeoplasmsSyphilis, CongenitalTracheal DiseasesBreast NeoplasmsNeutropeniaStevens-Johnson SyndromeFitness TrackersProgrammed Cell Death 1 ReceptorRespiratory Distress Syndrome, NewbornMonitoring, PhysiologicEsophageal StenosisNeoadjuvant TherapyInfant, Small for Gestational AgeRespiration DisordersAspergillosis, Allergic Bronchopulmonary

• Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer.
  Breast cancer research and treatment 2024 Umashankar S, Li M, Blevins K, Kim MO, Majure M, Park J, Huppert LA, Melisko M, Rugo HS, Esserman L, Chien AJ
• A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer.
  Breast cancer research and treatment 2023 Gumusay O, Huppert LA, Magbanua MJM, Wabl CA, Assefa M, Chien AJ, Melisko ME, Majure MC, Moasser M, Park J, Rugo HS
• Delayed immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors.
  Journal of Clinical Oncology 2023 Saya Jacob, Zoe Quandt, Michelle E. Melisko, Melanie Majure, Amy Jo Chien, Anne Hudson Blaes, Diane Heditsian, Laura Esserman, Hope S. Rugo
• Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: A single center retrospective cohort study.
  Journal of Clinical Oncology 2023 Laura Ann Huppert, Elene Tsopurashvili, Sai Sahitha Somepalle, Amy Jo Chien, Melanie Majure, Hope S. Rugo, Ronald Balassanian, Michelle E. Melisko
• Phase Ib study of talimogene laherparepvec (T-VEC) in combination with chemotherapy (CT) or endocrine therapy (ET) in patients with metastatic, unresectable, or locoregionally recurrent HER2-negative breast cancer (BC).
  Journal of Clinical Oncology 2023 Laura Ann Huppert, Amelia S Gliwa, Madeline Tait, Laura Quintal, Stephanie Starzinski, Alexander Cheung, Mark M. Moasser, Melanie Majure, Michelle E. Melisko, Hope S. Rugo, Pamela N. Munster, Michael …

Show all (27 more) Hide

• Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study.
  Breast cancer research and treatment 2022 Huppert LA, Walker Z, Li M, Kim MO, Callan J, Brandman D, Majure M, Melisko ME, Rugo HS, Behr S, Chien AJ
• Clinical and radiographic characteristics of patients with metastatic breast cancer and pseudocirrhosis: A single-center retrospective cohort study.
  Journal of Clinical Oncology 2022 Laura Ann Huppert, Zak Walker, Moming Li, Mi-Ok Kim, Jennie Callan, Melanie Majure, Michelle E. Melisko, Hope S. Rugo, Spencer Behr, Amy Jo Chien
• Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
  NPJ breast cancer 2021 Yee D, Isaacs C, Wolf DM, Yau C, Haluska P, Giridhar KV, Forero-Torres A, Jo Chien A, Wallace AM, Pusztai L, Albain KS, Ellis ED, Beckwith H, Haley BB, Elias AD, Boughey JC, Kemmer K, Yung RL, …
• Characterizing attitudes related to child-bearing in young women diagnosed with early breast cancer (EBC).
  Journal of Clinical Oncology 2021 Saumya Umashankar, Moming Li, Mi-Ok Kim, Hope S. Rugo, Michelle E. Melisko, Melanie Majure, John Park, Laura Esserman, Amy Jo Chien
• Abstract PS2-19: Circulating tumor cell (CTC) enumeration in a phase II trial of pazopanib in addition to endocrine therapy in patients with hormone resistant advanced breast cancer (ABC).
  Cancer Research 2021 Ozge Gumusay, Mark Jesus M. Magbanua, Melanie C. Majure, Travis Deal, Jonathan R. Renslo, Chiara A. Wabl, Michelle E. Melisko, A. Jo Chien, Andrei Goga, Mark M. Moasser, John W. Park, Jimmy Hwang, …
• A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression.
  Journal of Clinical Oncology 2020 Amy Jo Chien, Amelia S Gliwa, Siti Rahmaputri, Heidi F Dittrich, Melanie Catherine Majure, Hope S. Rugo, Michelle E. Melisko, Pamela N. Munster, John W. Park, Mark M. Moasser, Mehrdad Matloubian, …
• A phase Ib/II study of eribulin with cyclophosphamide (EC) in patients (pts) with advanced breast cancer (ABC).
  Journal of Clinical Oncology 2020 Ozge Gumusay, Jonathan R. Renslo, Chiara A. Wabl, Amy Jo Chien, Michelle E. Melisko, Melanie Catherine Majure, Siti D. Rahmaputri, Mark Moasser, John Park, Hope S. Rugo
• Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC).
  Journal of Clinical Oncology 2020 Ozge Gumusay, Melanie Catherine Majure, Travis Deal, Jonathan R. Renslo, Chiara A. Wabl, Michelle E. Melisko, Amy Jo Chien, Andrei Goga, Mark Moasser, John Park, Jimmy Hwang, Hope S. Rugo
• Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.
  JAMA oncology 2020 Nanda R, Liu MC, Yau C, Shatsky R, Pusztai L, Wallace A, Chien AJ, Forero-Torres A, Ellis E, Han H, Clark A, Albain K, Boughey JC, Jaskowiak NT, Elias A, Isaacs C, Kemmer K, Helsten T, Majure M, …
• Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy.
  Clinical breast cancer 2019 Dreher N, Hadeler EK, Hartman SJ, Wong EC, Acerbi I, Rugo HS, Majure MC, Chien AJ, Esserman LJ, Melisko ME
• A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC).
  Journal of Clinical Oncology 2019 Amy Jo Chien, Siti Rahmaputri, Heidi F Dittrich, Melanie Catherine Majure, Hope S. Rugo, Michelle E. Melisko, Andrei Goga
• The value of embedding: integrated palliative care for patients with metastatic breast cancer.
  Breast cancer research and treatment 2017 Rabow M, Small R, Jow A, Majure M, Chien A, Melisko M, Belkora J, Esserman LJ, Rugo H
• Objective assessment of physical activity during chemotherapy for breast cancer.
  Journal of Clinical Oncology 2017 Michelle E. Melisko, Edward Kenji Hadeler, Sandahl H Nelson, Audrey Lunde, Irene Acerbi, Hope S. Rugo, Melanie Catherine Majure, Amy Jo Chien, Laura Esserman, Sheri J. Hartman
• What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer.
  Annals of translational medicine 2016 Majure M, Logan AC
• Referral patterns among patients with metastatic breast cancer in an integrated palliative care program.
  Journal of Clinical Oncology 2016 Rebecca Small, Jeffrey Belkora, Melanie Catherine Majure, Amy Jo Chien, Michelle E. Melisko, Hope S. Rugo, Michael W. Rabow
• Addition of pazopanib (PZ) to endocrine therapy in hormone resistant advanced breast cancer (ABC).
  Journal of Clinical Oncology 2016 Melanie Catherine Majure, Ariadna Gasol Cudós, Austin Nicholas Angelidakis, Michelle E. Melisko, Ariel R. Karwat, Amy Jo Chien, Andrei Goga, Mark M. Moasser, John W. Park, Amy N. DeLuca, Hope S. Rugo
• Abstract P5-08-06: Comparison of risk prediction with the 21-gene recurrence score (oncotype DX) and the 70-gene signature (MammaPrint) in patients with estrogen receptor-positive early stage breast cancer.
  Poster Session Abstracts 2016 H Jiang, N Denduluri, M Majure, A Favret, HS Rugo
• Integrating outpatient palliative care into a metastatic breast oncology clinic.
  Journal of Clinical Oncology 2015 Rebecca Small, Jeffrey Belkora, Alexander Jow, Michael W. Rabow, Melanie Catherine Majure, Michelle E. Melisko, Amy Jo Chien, Hope S. Rugo
• Role of pazopanib (PZ) in modulating hormone resistance in advanced breast cancer (ABC).
  Journal of Clinical Oncology 2015 Melanie Catherine Majure, Michelle E. Melisko, Ariel R. Karwat, Amy Jo Chien, Andrei Goga, Mark M. Moasser, John W. Park, Amy N. DeLuca, Hope S. Rugo
• Management of Metastatic Breast Cancer.
  Breast Disease 2015 Sarah Keck, Melanie Majure, Hope S. Rugo
• Maintenance of tolerance by regulation of anti-myeloperoxidase B cells.
  Journal of the American Society of Nephrology : JASN 2008 Bunch DO, Silver JS, Majure MC, Sullivan P, Alcorta DA, Chin H, Hogan SL, Lindstrom YI, Clarke SH, Falk RJ, Nachman PH
• Inhalation of Francisella novicida Delta mglA causes replicative infection that elicits innate and adaptive responses but is not protective against invasive pneumonic tularemia.
  Microbes and infection 2008 West TE, Pelletier MR, Majure MC, Lembo A, Hajjar AM, Skerrett SJ
• Adeno-associated virus vector expressing nerve growth factor enhances cholinergic axonal sprouting after cortical injury in rats.
  The Journal of neuroscience : the official journal of the Society for Neuroscience 2003 Ramirez JJ, Caldwell JL, Majure M, Wessner DR, Klein RL, Meyer EM, King MA
• Severe laryngomalacia and bronchomalacia in DiGeorge syndrome and CHARGE association.
  Pediatric pulmonology 1997 Markert ML, Majure M, Harville TO, Hulka G, Oldham K
• A common presentation of an uncommon cause of neonatal respiratory distress: pneumonia alba.
  Pediatric pulmonology 1993 Edell DS, Davidson JJ, Mulvihill DM, Majure M
• Unusual manifestation of Stevens-Johnson syndrome involving the respiratory and gastrointestinal tract.
  Pediatrics 1992 Edell DS, Davidson JJ, Muelenaer AA, Majure M
• Risk factors for the development of posterior subcapsular cataracts in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis treated with corticosteroids.
  Pediatric pulmonology 1989 Majure M, Mroueh S, Spock A